LOX and colorectal cancer: The totality of evidence clearly supports the supposition that colorectal carcinogenesis often evolves as a progressive series of highly specific cellular and molecular changes in response to induction of constitutive overexpression of COX and LOX genes and their respective prostaglandins and leukotrienes in the “inflammogenesis of colorectal cancer”.